Related Experiment Videos
[Vaginal infections screening in pregnancy]
Z Hájek1, J Masata, P Svihovec
1Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha. hajekz@vfn.cz
Casopis Lekaru Ceskych
|December 13, 2005
Summary
Vaginal infections, often caused by bacteria, are a leading cause of preterm birth. Early screening and targeted antibiotic treatment for infections like bacterial vaginosis and chlamydia are crucial for preventing premature delivery.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Neonatal Health
Context:
- Preterm birth before 37 weeks gestation is frequently linked to ascending vaginal infections.
- Microbial invasion of the choriodecidual space triggers pro-inflammatory cytokines, leading to uterine contractions and premature rupture of membranes.
- Vaginal infections are a significant risk factor for preterm birth, impacting neonatal outcomes.
Purpose:
- To review the causes, diagnosis, and treatment of vaginal infections contributing to preterm birth.
- To highlight the importance of screening for specific infections in high-risk pregnancies and all pregnancies at term.
- To discuss current therapeutic strategies for common infections like bacterial vaginosis and chlamydial infections.
Summary:
- Aerobic and anaerobic bacteria ascending from the vagina are primary culprits in preterm birth.
- Screening for vaginal infections is recommended for imminent preterm labor and high-risk pregnancies, with specific guidelines for Streptococcus B screening.
- Effective treatments include Metronidazole or Clindamycin for bacterial vaginosis and Azithromycin for chlamydial infections, while asymptomatic bacteriuria treatment is not recommended.
Impact:
- Timely diagnosis and treatment of vaginal infections can reduce the incidence of preterm birth.
- Targeted screening and therapy improve neonatal outcomes by preventing infection-related complications.
- Understanding the role of pro-inflammatory cytokines in preterm labor informs diagnostic and therapeutic approaches.